Zhitong Finance App News, Jinling Pharmaceutical (000919.SZ) issued an announcement. Chizhou Dongsheng Pharmaceutical Co., Ltd., a holding subsidiary of the company, recently received the “Notice of Approval of the Marketing Application for Chemical Ingredients” for allolol hydrochloride issued by the State Drug Administration. Allolol hydrochloride is a receptor blocker that simultaneously blocks alpha and beta receptors. Its formulation products are mainly used to treat diseases such as essential hypertension (mild to moderate) and angina pectoris.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.